These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25908048)

  • 1. Loss of YAP protein in prostate cancer is associated with Gleason score increase.
    Hu X; Jia Y; Yu J; Chen J; Fu Q
    Tumori; 2015; 101(2):189-93. PubMed ID: 25908048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
    Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H; Chen Q; Luo Q
    Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells.
    Zhang S; Rong P; Chen Q; Wang W
    Life Sci; 2019 Sep; 232():116626. PubMed ID: 31276688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling.
    Wang R; Du Y; Shang J; Dang X; Niu G
    Mol Cell Probes; 2020 Oct; 53():101642. PubMed ID: 32645410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP expression in normal and neoplastic breast tissue: an immunohistochemical study.
    Jaramillo-Rodríguez Y; Cerda-Flores RM; Ruiz-Ramos R; López-Márquez FC; Calderón-Garcidueñas AL
    Arch Med Res; 2014 Apr; 45(3):223-8. PubMed ID: 24606817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 9. MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.
    Cao Z; Ji J; Wang FB; Kong C; Xu H; Xu YL; Chen X; Yu YW; Sun YH
    Asian J Androl; 2020; 22(6):616-622. PubMed ID: 32167077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
    Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
    Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.
    Hu XY; Xu YM; Fu Q; Yu JJ; Huang J
    Eur J Surg Oncol; 2009 May; 35(5):527-31. PubMed ID: 19004604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
    Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
    Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
    Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
    Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
    Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
    Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.
    Pan C; Du Z; Cai Z; Liu Y; Sun Y; Chen J; Tong T; Chen Q; Zhou L; Bing D; Tao Y; Chu H
    Mol Med Rep; 2017 Oct; 16(4):4934-4940. PubMed ID: 28791393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.